Navigation Links
Regulus Reports Third Quarter 2013 Financial Results and Recent Highlights
Date:11/13/2013

idates for clinical development in 2013, be positioned to file its first applications with regulatory authorities by the first half of 2014 and maintain a strong year-end cash position to support these goals. 

Regulus has demonstrated excellent progress on its 'Road to the Clinic' Strategy. In May, Regulus nominated its first microRNA candidate for clinical development, RG-101, a GalNAc-conjugated microRNA antagonist or anti-miR, which targets miR-122 for the treatment of HCV.  Regulus expects to file its first application with regulatory authorities for RG-101 in the near term and expects to commence clinical studies in man in early 2014.  Additionally, Regulus' strong financial position continues to support these stated goals and the Company continues to expect to end 2013 with approximately $110 million in cash, cash equivalents and short-term investments.  Lastly, Regulus expects that the second microRNA candidate to be nominated for clinical development by the end of the year may come from the miR-21 fibrosis program.

About RG-101 for the Treatment of HCVRG-101 is a key program in Regulus' 'Road to the Clinic' Strategy for 2013, in which the Company expects to nominate two microRNA candidates for clinical development, be positioned to file its first applications with regulatory authorities by the first half of 2014 and maintain a strong year-end cash position to support these goals.  RG-101 was the first microRNA candidate nominated for clinical development under this strategy.

microRNA-122 (miR-122) is the most abundant microRNA in hepatocytes and is a critical host factor for survival and replication of all know HCV genotypes.  RG-101 is a novel anti-miR-122 oligonucleotide therapeutic that is effectively targeted to hepatocytes for the treatment of HCV through conjugation to GalNAc, a carbohydrate-based chemistry approach for asialoglycoprotein receptor-mediated delivery of oligonucleotides to hepatocyte c
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Regulus Presents Positive Preclinical Data Demonstrating that microRNA-21 Plays an Important Role in Alport Syndrome
2. Regulus Announces Timing for Third Quarter 2013 Financial Results Webcast and Conference Call
3. Regulus Announces Significant Progress in Strategic Alliance with AstraZeneca and Selection of a New Pre-Clinically Validated microRNA Oncology Target
4. Regulus Reports Second Quarter 2013 Financial Results and Recent Highlights
5. Regulus Announces Timing for Second Quarter 2013 Financial Results Webcast and Conference Call
6. Regulus Names Stelios Papadopoulos, Ph.D. as Chairman of its Board of Directors
7. Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference
8. Regulus Provides Update on Road to the Clinic Strategy and Reports First Quarter 2013 Financial Results and Recent Highlights
9. Regulus Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
10. Regulus Appoints William H. Rastetter, Ph.D. to its Board of Directors
11. Regulus to Present at Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014  Decision Resources Group finds that the ... will remain relatively stagnant at a value of ... that percutaneous coronary intervention (PCI) volumes are growing faster in ... such as the United States and ... driven by the increase in penetration of PCI procedures relative ...
(Date:7/22/2014)... The number of people overdosing from opioid ... Twenty-three percent of the workforce has misused prescription painkillers, ... Health, making opioid use a serious threat to employee ... the correct dosage with a valid prescription, subtle impairment ... National Safety Council released a guide for employers, ...
(Date:7/22/2014)...  A central New York ... Total Artificial Heart implant is home, discharged from ... Freedom® portable driver to wait for a matching ... from a Syracuse architectural hardware company, suffered from ... medications, an implantable defibrillator and a pacemaker. ...
Breaking Medicine Technology:The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 35 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3
... WARSAW, Ind. , May 5 Zimmer Holdings, Inc. (NYSE: ... Merrill Lynch 2010 Health Care Conference in New York, New York , on ... , , ... website at http://investor.zimmer.com .  The webcast will be archived for replay following the conference. ...
... HARBIN, China , May 5 /PRNewswire-Asia-FirstCall/ ... a,developer, manufacturer and distributor of botanical products,bio-pharmaceuticals and traditional Chinese ... a Deputy Chair of Heilongjiang,Medical Association ("the Association") by members ... , , ...
Cached Medicine Technology:Zimmer Holdings to Present at Bank of America Merrill Lynch 2010 Health Care Conference 2Renhuang Elected as Deputy Chair Unit of Heilongjiang Medical Association 2Renhuang Elected as Deputy Chair Unit of Heilongjiang Medical Association 3Renhuang Elected as Deputy Chair Unit of Heilongjiang Medical Association 4
(Date:7/22/2014)... (PRWEB) July 22, 2014 A Florida ... ) that alleges the death of her husband ... the blood thinner, Bernstein Liebhard LLP reports. According to ... District Court for the Southern District of Florida on ... 2012, and suffered a subdural hemorrhage the following June. ...
(Date:7/22/2014)... (WASHINGTON, July 22, 2014) The American Society of ... Vanderbilt University School of Medicine, and Robert P. Hebbel, ... the 2014 Ernest Beutler Lecture and Prize for their ... disease. , The Ernest Beutler Lecture, named for the ... and physician-scientist for more than 50 years, is a ...
(Date:7/22/2014)... it comes to heart disease, Dr. Ross Feldman says women ... heart disease was a men,s-only disease, however, data has shown ... get heart disease and are less likely to be adequately ... this week in the British Journal of Clinical Pharmacology ... in women and helps to identify which women are more ...
(Date:7/22/2014)... 22, 2014 SIMpalm, a ... payment app for Forte Payment System. Forte Mobile Payment ... payments on iPhone, iPod and iPad. The app ... recently updated by SIMpalm. This update was for iOS ... supported on iOS 4.3 and is available to download ...
(Date:7/22/2014)... July 22, 2014 The Beryl Institute ... third annual Institute Scholar Program. These offerings reinforce the ... patient experience in healthcare and the need for rigorous ... grant and scholar programs are intended to ... Value of focusing on the patient experience before, ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 2Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 4Health News:Gene variant identified as a heart disease risk factor for women 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 3
... nortriptyline than escitalopram, study finds , THURSDAY, Oct. 15 ... (Aventyl) are nearly 10 times more likely to have ... (Lexapro, Cipralex), a new study has found. , The ... , included 811 people with moderate to severe ...
... and Choice of Physician , Senate Considers ... 15 Seniors and their physicians moved a step closer ... this week with legislation (S. 1776) under consideration in the ... this essential element of health reform, the American Medical Association ...
... HARBIN, China, Oct. 15 /PRNewswire-Asia-FirstCall/-- SOKO Fitness & ... reported the,operating results for the first quarter of financial ... grew 50% to $6.43 million from $4.28 million in,the ... quarter grew 68% to $2.43,million and fully diluted earnings ...
... radiation, researchers say , THURSDAY, Oct. 15 (HealthDay ... better than yellow at protecting skin against damaging ultraviolet ... , The researchers said their findings could lead to ... color of fabric is one of the most critical ...
... "S,more to Love", a cocktail fundraiser on Friday, November 6, 2009 ... Family Camp. , Celebrating its 20th year, the Birch Family Camp ... boroughs of NYC, along with 200 volunteers for a week of ... the Hudson Valley. Throughout the year this community helps each ...
... The Longaberger Company is teaming up with the National ... breast cancer. As part of the "Crucial Catch" campaign throughout ... - in partnership with the American Cancer Society - are ... players, coaches and referees wearing pink game apparel to raise ...
Cached Medicine News:Health News:AMA Medicare Campaign Kicks-Off With New TV Ads 2Health News:AMA Medicare Campaign Kicks-Off With New TV Ads 3Health News:SOKO Fitness & Spa Group Reports Quarterly Earnings Growth Over Fiscal 2009 First Quarter 2Health News:SOKO Fitness & Spa Group Reports Quarterly Earnings Growth Over Fiscal 2009 First Quarter 3Health News:SOKO Fitness & Spa Group Reports Quarterly Earnings Growth Over Fiscal 2009 First Quarter 4Health News:SOKO Fitness & Spa Group Reports Quarterly Earnings Growth Over Fiscal 2009 First Quarter 5Health News:SOKO Fitness & Spa Group Reports Quarterly Earnings Growth Over Fiscal 2009 First Quarter 6Health News:SOKO Fitness & Spa Group Reports Quarterly Earnings Growth Over Fiscal 2009 First Quarter 7Health News:One Heartland Hosting: S'more to Love Cocktail Fundraiser 2
Safilo Design, a state-of-the art ophthalmic collection that blends technology with minimalist sophistication. Each style comes with a sleek silver-colored hard case with magnetic closure....
Inquire...
Classic, stylish, and preppy, this collection features men's, women's and unisex styles....
The latest VALENTINO eyewear collection is a refined expression of sophisticated luxury,balancing ultimate feminine, chic styles against understated, minimalist mens models....
Medicine Products: